You are here:

Shire Pharmaceuticals

Name SMC ID No Status Sub. Type
 
Anagrelide 0.5mg capsule (Xagrid®) 163/05 Accepted Resubmission
Anagrelide 0.5mg capsule (Xagrid®) 163/05 Not Recommended Full submission
Eflornithine 11.5% cream (Vaniqa®) 159/05 Restricted Resubmission
Eflornithine 11.5% cream (Vaniqa®) 159/05 Not Recommended Full submission
epoetin delta prefilled syringe (Dynepo) 418/07 Marketing Authorisation Withdrawn Full submission
guanfacine hydrochloride (Intuniv) 1123/16 Accepted Full submission
hydrocortisone (Plenadren) 848/12 Not Recommended Full submission
icatibant (Firazyr) 476/08 Accepted Resubmission
idursulfase 2mg/ml concentrate for solution for infusion (Elaprase) 391/07 Not Recommended Full submission
lanthanum carbonate (Fosrenol) 640/10 Not Recommended Full submission
lanthanum carbonate (Fosrenol) 821/12 Restricted Abbreviated Submission
lanthanum carbonate 500, 750, 1000mg chewable tablets (Fosrenol) 286/06 Restricted Full submission
liposomal irinotecan (Onivyde) 1217/17 Not Recommended Full submission
lisdexamfetamine dimesylate (Elvanse Adult) 1079/15 Accepted Full submission
lisdexamfetamine dimesylate (Elvanse) 863/13 Accepted Full submission
mesalazine 1200mg gastro-resistant prolonged release tablet (Mezavant XL) 445/08 Accepted Abbreviated Submission
Reminyl XL® 139/04 Superseded Abbreviated Submission
velaglucerase (Vpriv) 681/11 Not Recommended Non submission
velaglucerase (Vpriv) 681/11 Accepted Full submission

Back